These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7979292)

  • 1. Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia.
    Roblin PM; Montalban G; Hammerschlag MR
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1588-9. PubMed ID: 7979292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
    Hammerschlag MR; Roblin PM
    Int J Antimicrob Agents; 2000 Jul; 15(2):149-52. PubMed ID: 10854812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
    Hammerschlag MR; Reznik T; Roblin PM; Ramirez J; Summersgill J; Bukofzer S
    J Antimicrob Chemother; 2003 Apr; 51(4):1025-8. PubMed ID: 12654764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia.
    Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1998 Jan; 42(1):194-6. PubMed ID: 9449287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae.
    Hammerschlag MR; Qumei KK; Roblin PM
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1573-4. PubMed ID: 1324650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae.
    Welsh L; Gaydos C; Quinn TC
    Antimicrob Agents Chemother; 1996 Jan; 40(1):212-4. PubMed ID: 8787907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
    Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T
    J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
    Roblin PM; Kohlhoff SA; Parker C; Hammerschlag MR
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1358-9. PubMed ID: 20038627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.
    Strigl S; Roblin PM; Reznik T; Hammerschlag MR
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1112-3. PubMed ID: 10722526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.
    Block S; Hedrick J; Hammerschlag MR; Cassell GH; Craft JC
    Pediatr Infect Dis J; 1995 Jun; 14(6):471-7. PubMed ID: 7667050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
    Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1515-6. PubMed ID: 9624507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.
    Roblin PM; Hammerschlag MR
    Int J Antimicrob Agents; 2000 Sep; 16(1):61-3. PubMed ID: 11185415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of garenoxacin against Chlamydia spp.
    Donati M; Pollini GM; Sparacino M; Fortugno MT; Laghi E; Cevenini R
    J Antimicrob Chemother; 2002 Sep; 50(3):407-10. PubMed ID: 12205067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.
    Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1998 Apr; 42(4):951-2. PubMed ID: 9559818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.
    Kuo CC; Jackson LA; Lee A; Grayston JT
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2669-70. PubMed ID: 8913488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniae.
    Roblin PM; Reznik T; Hammerschlag MR
    Int J Antimicrob Agents; 2003 Jun; 21(6):578-80. PubMed ID: 12791473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation of Chlamydia pneumoniae in atypical pneumonia].
    Maass M; Dalhoff K
    Dtsch Med Wochenschr; 1994 Oct; 119(43):1462-6. PubMed ID: 7956770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of erythromycin and clarithromicin against isolates of Streptococcus pneumoniae with decreased sensitivity to penicillin obtained from healty carriers. Spanish Collaborative Group].
    García de Lomas J; Gimeno C; Navarro D; Millás E; Bermejo M; Lázaro MA; Garijo B
    Enferm Infecc Microbiol Clin; 1996; 14(7):422-5. PubMed ID: 8991436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Chlamydia pneumoniae.
    Hammerschlag MR
    Int J Antimicrob Agents; 2000 Aug; 15(3):239, 241. PubMed ID: 10926449
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycoplasma pneumoniae and Chlamydia pneumoniae chronic cough in children: efficacy of clarithromycin.
    Velissariou IM; Papadopoulos NG; Giannaki M; Tsolia M; Saxoni-Papageorgiou P; Kafetzis DA
    Int J Antimicrob Agents; 2005 Aug; 26(2):179-80. PubMed ID: 16023330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.